Skip to main content
    B

    Bausch Health Companies Inc (BHC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $6.32
    +0.43 (+7.30%)

    Market Cap: $2.20B

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    74%(29/39)
    Avg Surprise
    +5.06%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.22
    Range$1.01 - $1.38
    6 analysts
    EPS Revisions
    2
    0
    7d
    1
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$1.28-4.4%
    60d ago$1.19+2.7%
    30d ago$1.19+2.7%
    7d ago$1.22+0.7%
    Current$1.22
    Revenue Consensus
    $2.8B
    Range$2.7B - $2.8B
    4 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.55
    Range$1.11 - $1.84
    6 analysts
    Revenue Consensus
    $3.1B
    Range$2.9B - $3.1B
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.55---
    Sep 26EST
    		-$1.22---
    Jun 26
    Reported Jul 29
    		$1.26$0.96+31.25%Beat+38.5%
    Mar 26
    Reported Apr 29
    		$0.78$0.69+13.04%Beat+27.9%
    Dec 25
    Reported Feb 18
    		$1.08$1.21-10.74%Miss-6.9%
    Sep 25
    Reported Oct 29
    		$1.16$1.06+9.43%Beat+2.7%
    Jun 25
    Reported Jul 30
    		$0.91$0.94-3.19%Miss-7.1%
    Mar 25
    Reported Apr 30
    		$0.61$0.85-28.24%Miss+3.4%
    Dec 24
    Reported Feb 19
    		$1.16$1.13+2.96%Beat+0.9%
    Sep 24
    Reported Oct 30
    		$1.13$1.02+10.78%Beat+9.7%
    Jun 24
    Reported Aug 1
    		$0.98$0.88+11.36%Beat+21.0%
    Mar 24
    Reported May 2
    		$0.59$0.72-18.06%Miss+11.3%
    Dec 23
    Reported Feb 22
    		$1.15$1.02+12.75%Beat+11.7%
    Sep 23
    Reported Nov 2
    		$1.03$0.92+11.96%Beat+35.5%
    Jun 23
    Reported Aug 3
    		$0.81$0.73+10.96%Beat+47.3%
    Mar 23
    Reported May 4
    		$0.53$0.68-22.06%Miss-26.4%
    Dec 22
    Reported Feb 23
    		$1.03$0.95+8.42%Beat-19.5%
    Sep 22
    Reported Nov 3
    		$0.76$0.78-2.56%Miss-33.9%
    Jun 22
    Reported Aug 9
    		$0.55$0.91-39.56%Miss-43.3%
    Mar 22
    Reported May 10
    		$0.72$1.03-30.10%Miss-29.4%
    Dec 21
    Reported Feb 23
    		$1.28$1.12+14.29%Beat-3.8%
    Sep 21
    Reported Nov 2
    		$1.15$1.06+8.49%Beat-12.2%
    Jun 21
    Reported Aug 3
    		$0.97$0.95+2.11%Beat+110.9%
    Mar 21
    Reported May 4
    		$1.02$0.95+7.37%Beat+14.6%
    Dec 20
    Reported Feb 24
    		$1.33$1.12+18.75%Beat+15.7%
    Sep 20
    Reported Nov 3
    		$1.31$1.04+25.96%Beat+8.3%
    Jun 20
    Reported Aug 6
    		$0.46$0.65-29.23%Miss-57.0%
    Mar 20
    Reported May 7
    		$0.89$0.88+1.14%Beat-13.6%
    Dec 19
    Reported Feb 19
    		$1.15$1.13+1.77%Beat+11.7%
    Sep 19
    Reported Nov 4
    		$1.21$1.09+11.01%Beat+5.2%
    Jun 19
    Reported Aug 6
    		$1.07$1.06+0.94%Beat+15.1%
    Mar 19
    Reported May 6
    		$1.03$0.86+19.77%Beat+17.0%
    Dec 18
    Reported Feb 20
    		$1.03$0.84+22.62%Beat+5.1%
    Sep 18
    Reported Nov 6
    		$1.15$0.86+33.72%Beat+10.6%
    Jun 18
    Reported Aug 7
    		$0.93$0.80+16.25%Beat-11.4%
    Mar 18
    Reported May 8
    		$0.88$0.60+46.67%Beat+12.8%
    Dec 17
    Reported Feb 28
    		$0.98$0.97+1.03%Beat-22.2%
    Sep 17
    Reported Nov 7
    		$1.04$0.89+16.85%Beat-
    Jun 17
    Reported Aug 8
    		$1.05$0.96+9.38%Beat-
    Mar 17
    Reported May 9
    		$0.78$0.82-4.88%Miss-
    Dec 16
    Reported Feb 28
    		$1.26$1.20+5.00%Beat-

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    Payout Ratio0.00%
    No dividend payments in the selected period.

    Key Metrics

    Valuation
    P/E Ratio1.48EV/EBITDA10.05x
    Price/FCF1.66xFCF Yield60.38%
    Profitability
    Profit Margin-10.10%Operating Margin27.20%
    ROE43.60%ROIC4.46%
    Financial Health
    Debt/Equity-11.71xInterest Coverage0.52x
    Current Ratio1.44xQuick Ratio1.08x
    Trading Statistics
    Beta0.37Avg Volume1.86M
    52-Week High$8.0052-Week Low$4.33

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$6.00
    SMA 20$5.86
    SMA 50$6.15
    SMA 200$5.73
    EMA 10$6.00
    EMA 20$5.97
    EMA 50$5.93
    EMA 200$5.79

    MACD

    Line: 0.02Signal: -0.03Hist: 0.04

    ADX

    ADX: 14.6+DI: 26.7-DI: 16.0

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down40.0
    PSAR$5.73

    Bollinger Bands

    Upper Band$6.22
    Lower Band$5.51
    %B Position1221%(Upper)
    Band Width1.14

    RSI (14-Day)

    Neutral
    61.9

    Momentum Oscillators

    Stoch %K59.6
    Stoch %D51.7
    Williams %R-4.0
    ROC (10d)10.3%
    Momentum0.59
    CCI (20d)163.0
    MFI (14d)69.7

    Volatility Measures

    ATR (14d)$0.27(4.3%)
    StdDev (20d)0.18
    Hist Vol33.9%(Moderate)

    Volume Flow

    VWAP$6.21
    OBV103.1M
    AD Line10.5M
    CMF (20d)0.106

    Volume Metrics

    Avg Vol (20d)1.8M
    Vol Ratio1.3x
    VWMA (20d)$5.87

    Pivot Points

    R3$6.21
    R2$6.13
    R1$6.01
    Pivot Point$5.93
    S1$5.81
    S2$5.73
    S3$5.61

    Advanced Oscillators

    TSI1.75
    Ultimate Osc48.5
    KST-28.35

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.85B$2.52B$2.80B$2.68B$2.53B$2.26B$2.56B$2.51B$2.40B$2.15B$2.41B$2.24B
    Cost of Revenue$772.00M$738.00M$798.00M$750.00M$764.00M$701.00M$727.00M$696.00M$719.00M$640.00M$705.00M$623.00M
    Gross Profit$2.08B$1.79B$2.00B$1.93B$1.77B$1.56B$1.83B$1.81B$1.68B$1.51B$1.70B$1.61B
    Operating Expenses$1.34B$2.74B$1.52B$1.31B$1.32B$1.28B$1.27B$1.50B$1.29B$1.23B$1.34B$1.60B
    R&D$173.00M$163.00M$161.00M$166.00M$159.00M$143.00M$163.00M$146.00M$156.00M$151.00M$152.00M$153.00M
    SG&A$907.00M$861.00M$882.00M$795.00M$894.00M$867.00M$820.00M$850.00M$832.00M$794.00M$766.00M$715.00M
    Operating Income$740.00M$-950,000,000$474.00M$619.00M$444.00M$276.00M$558.00M$318.00M$389.00M$281.00M$362.00M$14.00M
    Interest Income$11.00M$10.00M$9.00M$15.00M$13.00M$11.00M$9.00M$7.00M$8.00M$9.00M$7.00M$6.00M
    Interest Expense$396.00M$403.00M$416.00M$409.00M$287.00M$330.00M$337.00M$346.00M$338.00M$344.00M$362.00M$339.00M
    Income Before Tax$348.00M$-1,354,000,000$56.00M$218.00M$140.00M$-47,000,000$209.00M$-21,000,000$48.00M$-69,000,000$-7,000,000$-326,000,000
    Income Tax Expense$88.00M$77.00M$159.00M$37.00M$12.00M$39.00M$111.00M$71.00M$49.00M$8.00M$40.00M$56.00M
    Net Income$260.00M$-1,431,000,000$-103,000,000$181.00M$128.00M$-86,000,000$98.00M$-92,000,000$-1,000,000$-77,000,000$-47,000,000$-382,000,000
    EBITDA$1.03B$-649,000,000$777.00M$954.00M$782.00M$614.00M$879.00M$674.00M$730.00M$620.00M$714.00M$336.00M
    EBIT$733.00M$-961,000,000$463.00M$612.00M$414.00M$272.00M$537.00M$318.00M$378.00M$266.00M$348.00M$7.00M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about BHC

    News

    Bausch Health (TSX:BHC): What Did The Salix Cirrhosis Pilot Show?

    Bausch Health's Salix Pharmaceuticals presented preliminary results from a pilot study demonstrating improved adherence to guideline-based cirrhosis care in community gastroenterology practices. The study utilized...

    Kalkine Media•10/13/26•Somewhat-Bullish

    Dilution adjustment of Bausch Health Companies Inc. – HAN:BVF

    This article from TradingView is a brief notification about a dilution adjustment for Bausch Health Companies Inc. (HAN:BVF). It appears to be a financial update provided by the platform...

    TradingView•10/12/26•Neutral

    Thomas J. Appio Named Interim CEO of Bausch + Lomb as Brent Saunders Departs

    Thomas J. Appio, chairman of Bausch + Lomb's board and CEO of Bausch Health, has been appointed interim CEO of Bausch + Lomb following Brent Saunders' departure. Appio will continue his role at Bausch Health while...

    VisionMonday.com•10/12/26•Somewhat-Bullish

    Why Is Bausch + Lomb Stock Falling Monday?

    Bausch + Lomb (BLCO) stock fell nearly 10% on Monday after the company announced an unexpected leadership change, with Thomas J. Appio appointed interim CEO, replacing Brent Saunders. Despite the shake-up...

    Benzinga•10/12/26•Somewhat-Bearish

    Thomas J. Appio Named Interim CEO of Bausch + Lomb as Brent Saunders Departs

    Thomas J. Appio, chairman of Bausch + Lomb's board and CEO of Bausch Health, has been appointed interim CEO of Bausch + Lomb following Brent Saunders' departure. Appio will continue his role at Bausch Health while...

    VisionMonday.com•10/12/26•Somewhat-Bullish

    BHC Valuation and Fair Value

    P/E
    1.5x
    Forward P/E
    1.3x
    EV/EBITDA
    10.1x
    P/FCF
    1.7x
    PEG
    0.0x
    P/B
    -1.3x
    See GNG's fair value

    BHC Profitability: Margins, ROIC and FCF

    Gross margin
    71.8%
    Operating margin
    27.2%
    Net margin
    -10.1%
    ROIC
    4.5%
    ROE
    43.6%
    FCF margin
    13.2%
    FCF yield
    60.4%

    BHC Competitors

    CompanyTicker
    Perrigo Company PLCPRGO
    NeoGenomics IncNEO
    Day One Biopharmaceuticals IncDAWN
    Celldex Therapeutics IncCLDX
    UFP Technologies IncUFPT
    Harmony Biosciences HoldingsHRMY
    Prestige Brand Holdings IncPBH
    Aurinia Pharmaceuticals IncAUPH

    Sector: Healthcare

    BHC Analyst Ratings

    Consensus
    Hold
    Analysts
    7
    Strong Buy
    0
    Buy
    0
    Hold
    7
    Sell
    0
    Strong Sell
    0

    BHC Bull Case vs Bear Case

    Bull case

    • BHC grew quarterly revenue 12.7% year over year.

    Bear case

    • BHC has a -10.1% net profit margin.

    BHC Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    3.2%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $1.22
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 2 down

    BHC Dividend

    Forward yield
    0.0%
    Payout ratio
    0.0%

    Frequently Asked Questions About BHC

    Does BHC pay dividends?

    Bausch Health Companies Inc (BHC) has a dividend payment track record. See the BHC dividend history page for its current payment status, TTM yield, and recorded payments.

    What is BHC's P/E ratio?

    Bausch Health Companies Inc has a price-to-earnings (P/E) ratio of 1.48.

    What is BHC's market cap?

    Bausch Health Companies Inc (BHC) has a market capitalization of $2.20B with a current stock price of $6.32.

    Related stocks

    Sector: Healthcare

    All stocks starting with B

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In